tert-Butyl 1-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12-tetraoxapentadecan-15-oate
97%
- Product Code: 63036
CAS:
518044-36-5
| Molecular Weight: | 401.45 g./mol | Molecular Formula: | C₁₉H₃₁NO₈ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22683300 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
This chemical is primarily utilized in the field of bioconjugation and protein modification. It serves as a linker molecule, enabling the attachment of various functional groups or molecules to proteins or peptides. Its structure, featuring a reactive pyrrole dione moiety, allows for efficient and selective conjugation under mild conditions. This makes it valuable in the development of antibody-drug conjugates (ADCs), where it helps in linking cytotoxic drugs to antibodies for targeted cancer therapy. Additionally, it is employed in the synthesis of polymer-drug conjugates, enhancing the solubility and stability of therapeutic agents. The compound’s polyethylene glycol (PEG) chain further improves biocompatibility and reduces immunogenicity, making it suitable for biomedical applications.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | ฿13,167.00 |
+
-
|
tert-Butyl 1-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12-tetraoxapentadecan-15-oate
This chemical is primarily utilized in the field of bioconjugation and protein modification. It serves as a linker molecule, enabling the attachment of various functional groups or molecules to proteins or peptides. Its structure, featuring a reactive pyrrole dione moiety, allows for efficient and selective conjugation under mild conditions. This makes it valuable in the development of antibody-drug conjugates (ADCs), where it helps in linking cytotoxic drugs to antibodies for targeted cancer therapy. Additionally, it is employed in the synthesis of polymer-drug conjugates, enhancing the solubility and stability of therapeutic agents. The compound’s polyethylene glycol (PEG) chain further improves biocompatibility and reduces immunogenicity, making it suitable for biomedical applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :